Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review.
BNT162b2
Covid-19
erythema nodosum
mRNA vaccine
side effects
vaccination
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
28
03
2022
received:
23
12
2021
accepted:
31
03
2022
pubmed:
19
4
2022
medline:
18
1
2023
entrez:
18
4
2022
Statut:
ppublish
Résumé
Erythema nodosum (EN), the most common form of panniculitis, is a reactive inflammation of the subcutaneous fat clinically presented with a sudden onset of painful, erythematous, nodular, subcutaneous lesions, typically localized to the pretibial area. EN is commonly caused by numerous infections (especially beta-haemolytic streptococcal infections), autoimmune diseases (sarcoidosis), inflammatory bowel conditions and drugs. EN induced by Covid-19 vaccines is rarely reported. We describe an original clinical observation of a 75-year-old woman who presented with EN after receiving the second dose of BNT162b2, an mRNA vaccine.
Identifiants
pubmed: 35434826
doi: 10.1111/bcp.15351
pmc: PMC9111509
doi:
Substances chimiques
BNT162 Vaccine
0
COVID-19 Vaccines
0
Types de publication
Case Reports
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
536-540Informations de copyright
© 2022 British Pharmacological Society.
Références
Requena L, Yus ES. Erythema nodosum. Dermatol Clin. 2008;26(4):425-438. doi:10.1016/j.det.2008.05.014
Schwartz RA, Nervi SJ. Erythema nodosum: A sign of systemic disease. Am Fam Physician. 2007;75(5):695-700.
Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36(6-7):424-427. doi:10.1080/00365540410027184
Leung AKC, Leong KF, Lam JM. Erythema nodosum. World J Pediatr. 2018;14(6):548-554. doi:10.1007/s12519-018-0191-1
Cohen PR. Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine-associated erythema nodosum. Dermatol Ther. 2013;3(2):191-197. doi:10.1007/s13555-013-0035-9
Iannone P, Castellini G, Coclite D, et al. The need of health policy perspective to protect healthcare workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectiveness. PLoS ONE. 2020;15(6):e0234025. doi:10.1371/journal.pone.0234025
Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9(4):1423-1437. doi:10.1016/j.jaip.2020.12.047
Mehta H, Handa S, Malhotra P, et al. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India. J Eur Acad Dermatol Venereol. 2022;36(1):e16-e18.
Aly MH, Alshehri AA, Mohammed A, et al. First case of erythema nodosum associated with Pfizer vaccine. Cureus. 2021;13(11):e19529. doi:10.7759/cureus.19529
Wu X, Lim JHL, Lee JSS, Chio MT-W. Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. JAAD Int. 2022;6:107-108. doi:10.1016/j.jdin.2021.12.009
Cameli N, Silvestri M, Mariano M, Bennardo L, Nisticò SP, Cristaudo A. Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine. J Eur Acad Dermatol Venereol. 2022;36(3):e161-e162. doi:10.1111/jdv.17762
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154
Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther. 2010;23(4):320-327. doi:10.1111/j.1529-8019.2010.01332.x
Polycarpou A, Walker SL, Lockwood DN. A systematic review of immunological studies of erythema nodosum leprosum. Front Immunol. 2017;8:233. doi:10.3389/fimmu.2017.00233
Kaliyadan F, Dharmaratnam AM. Erythema nodosum - an association with rabies vaccination. Dermatol Online J. 2008;14(6):22. doi:10.5070/D34vw9v3cs
Wu Y-L, Tsai M-H, Liu L-L. Erythema nodosum and hepatitis B: a case report and literature review. J Microbiol Immunol Infect. 2008;41(5):437-439.
Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with SARS-CoV-2 vaccines. J Clin Med. 2021;10(22):5344.
McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46-55. doi:10.1016/j.jaad.2021.03.092
Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2021;186(1):142-152. doi:10.1111/bjd.20639
Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol. 2022;49(1):34-41. doi:10.1111/cup.14104
Holmes GA, Desai M, Limone B, et al. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Rep. 2021;16:53-57. doi:10.1016/j.jdcr.2021.07.038
Corbeddu M, Diociaiuti A, Vinci MR, et al. Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 vaccine: an Italian single-centre case series. J Eur Acad Dermatol Venereol. 2021;35(8):e483-e485. doi:10.1111/jdv.17268
Tomayko MM, Damsky W, Fathy R, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol. 2021;148(3):750-751. doi:10.1016/j.jaci.2021.06.026
Annabi E, Dupin N, Sohier P, et al. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. J Eur Acad Dermatol Venereol. 2021;35(12):e847-e850. doi:10.1111/jdv.17578
Sotiriou E, Tsentemeidou A, Bakirtzi K, Lallas A, Ioannides D, Vakirlis E. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre. J Eur Acad Dermatol Venereol. 2021;35(12):e857-e859. doi:10.1111/jdv.17582
Vastarella M, Picone V, Martora F, Fabbrocini G. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series. J Eur Acad Dermatol Venereol. 2021;35(12):e845-e846. doi:10.1111/jdv.17576
Rademacher J-G, Tampe B, Korsten P. First report of two cases of Löfgren's syndrome after SARS-CoV-2 vaccination: Coincidence or causality? Vaccine. 2021;9(11):1313.
Salvatore MA, Lynch PJ. Erythema nodosum, estrogens, and pregnancy. Arch Dermatol. 1980;116(5):557-558. doi:10.1001/archderm.1980.01640290067014
Suter P, Mooser B, Thien HPPH. Erythema nodosum as a cutaneous manifestation of COVID-19 infection. BMJ Case Rep. 2020;13(7):e236613.
Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccine. 2021;9(5):435.
Polat A, Dinulescu M, Fraitag S, et al. Skin manifestations among GATA2-deficient patients. Br J Dermatol. 2018;178(3):781-785. doi:10.1111/bjd.15548